Intrinsic Value

The intrinsic value of Bio-Techne Corp (TE1) under the Base Case is 54.86 EUR per share. Compared with the current market price of 64.94 EUR, the stock appears Overvalued by 16% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

TE1 Intrinsic Value
€54.86
Overvaluation 16%
Intrinsic Value
Price €64.94
Alert me when TE1 is below its intrinsic value
Today €43.89 · 32.4% below the current price

TE1 is valued in line with its history. A premium of this size has been typical over the past 5 years.

Alternatives to TE1

Fundamental Analysis

What Bio-Techne Does

Life Sciences Tools & Services Health Care

Bio-Techne makes the tools scientists use to study cells and disease. Its products include antibodies, proteins, assays, cell and gene therapy reagents, and instruments used in life-science research and clinical testing. The company also sells diagnostic products that help labs detect and monitor certain medical conditions.

Headquarters
United States of America US
Employees
3 100
IPO date
Feb 9, 1989
Read the full company overview
View Company Overview

Bio-Techne has a narrow economic moat

No Moat Narrow Wide

Patents on RNAscope probe designs make it harder for rivals to copy some of Bio-Techne’s spatial biology products, and labs may need time and repeat testing to change research workflows built around its validated reagents and instruments. These advantages protect specific products and customer relationships, while many of its markets still have competing suppliers.

Read the full moat analysis
Financials
Efficiency

Earnings Waterfall
Bio-Techne Corp

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Ownership

TECH Insider Trading
Buy and sell transactions by insiders

Continue TE1 Research

Decided on Bio-Techne? Get an email when TE1 reaches the price you’d buy at. Free with an account.

Other Bio-Techne listings

What is the Intrinsic Value of one TE1 stock?

The intrinsic value for Bio-Techne Corp (TE1) under the Base Case is 54.86 EUR.

Is TE1 stock undervalued or overvalued?

Compared with the current market price of 64.94 EUR, the stock appears Overvalued by 16% .

How reliable are our estimates? See how past valuations played out
Back to Top